Zevra Therapeutics, Inc. Property, Plant and Equipment
Zevra Therapeutics, Inc. (ZVRA) had Property, Plant and Equipment of $641.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-05
- 2026-06-30: Property, Plant and Equipment, Net $641.00K.
- 2026-03-31: Property, Plant and Equipment, Net $430.00K.
- 2025-12-31: Property, Plant and Equipment, Net $489.00K.
- 2025-09-30: Property, Plant and Equipment, Net $488.00K.
| Period end | Property, Plant and Equipment, Net |
|---|---|
| 2026-06-30 | $641.00K 10-Q · filed 2026-08-05 |
| 2026-03-31 | $430.00K 10-Q · filed 2026-05-06 |
| 2025-12-31 | $489.00K 10-Q · filed 2026-08-05 |
| 2025-09-30 | $488.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $599.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $422.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $356.00K 10-K · filed 2026-03-09 |
| 2024-09-30 | $607.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $678.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $695.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $736.00K 10-K · filed 2025-03-12 |
| 2023-09-30 | $642.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $689.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $744.00K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $794.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $852.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $904.00K 10-Q · filed 2022-08-12 |
| 2022-03-31 | $835.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $884.00K 10-K · filed 2023-03-07 |
| 2021-09-30 | $931.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $992.00K 10-Q · filed 2021-08-13 |
| 2021-03-31 | $975.00K 10-Q · filed 2021-05-14 |
| 2020-12-31 | $1.04M 10-K · filed 2022-03-31 |
| 2020-09-30 | $1.08M 10-Q · filed 2020-10-30 |
| 2020-06-30 | $1.15M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $1.21M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $1.47M 10-K · filed 2021-03-12 |
| 2019-09-30 | $1.54M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.61M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $1.69M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $1.75M 10-K · filed 2020-02-28 |
| 2018-09-30 | $1.82M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $1.84M 10-Q · filed 2018-08-10 |
| 2018-03-31 | $1.92M 10-Q · filed 2018-05-11 |
| 2017-12-31 | $2.00M 10-K · filed 2019-03-01 |
| 2017-09-30 | $2.09M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $2.15M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $2.20M 10-Q · filed 2017-05-22 |
| 2016-12-31 | $1.97M 10-K · filed 2018-03-30 |
| 2016-09-30 | $1.46M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $1.10M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $443.00K 10-Q · filed 2016-05-13 |
| 2015-12-31 | $403.00K 10-K · filed 2017-03-10 |
| 2015-09-30 | $386.00K 10-Q · filed 2015-11-13 |
| 2015-06-30 | $352.00K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $354.00K 10-Q · filed 2015-05-29 |
| 2014-12-31 | $352.00K 10-K · filed 2016-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |